Siyu Wang

Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases

China

SCHOLARLY PAPERS

3

DOWNLOADS

251

SSRN CITATIONS
Rank 48,255

SSRN RANKINGS

Top 48,255

in Total Papers Citations

17

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Treatment with Human Umbilical Cord-Derived Mesenchymal Stem Cells for Severe COVID-19 Patients with Lung Damage: A Randomised, Double-Blind, Placebo‑Controlled Phase 2 Trial

Number of pages: 36 Posted: 14 Oct 2020
Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Second Military Medical University - Department of Respiratory, Wuhan Huoshenshan Hospital, Peking University - Clinical Research Institute, General Hospital of Central Theater Command - Department of Infectious Disease, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Fifth Medical Center of Chinese PLA General Hospital, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Chinese PLA General - Department of Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Wuhan Huoshenshan Hospital, Huazhong University of Science and Technology - Department of Hematology, Wuhan Huoshenshan Hospital, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Department of Endocrinology and Metabolism, Huazhong University of Science and Technology - Department of Radiology, Wuhan Huoshenshan Hospital, General Hospital of Central Theater Command - Department of Infectious Disease, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - General Hospital of Beijing Military Region, Chinese PLA General Hospital - Department of Infectious Diseases, Peking University - Clinical Research Institute, Wuhan Huoshenshan Hospital, Wuhan Huoshenshan Hospital, Wuhan Huoshenshan Hospital, Peking University - Clinical Research Institute, Government of the People's Republic of China - Department of Gastroenterology and Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases
Downloads 110 (451,337)
Citation 7

Abstract:

Loading...

COVID-19, Mesenchymal stem cells, Randomised controlled trial

2.

Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy in COVID-19 Patients: A Phase 1 Clinical Trial

Number of pages: 32 Posted: 14 Jul 2020
Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, 302 Military Hospital of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Champalimaud Foundation - Champalimaud Center for the Unknown, University College London - National Institute for Health and Care Research Biomedical Research Centre, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases and Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases
Downloads 88 (524,182)
Citation 8

Abstract:

Loading...

3.

Human Mesenchymal Stem Cells Treatment for Severe COVID-19: 1-Year Follow-Up Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Number of pages: 35 Posted: 28 Jul 2021
Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Huazhong University of Science and Technology - Department of Hematology, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China -Department of Infectious Disease, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Chinese PLA General - Department of Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Department of Radiology, Government of the People's Republic of China - Department of Radiology, Wuhan Kingmed Center for Clinical Laboratory Co., Ltd., Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, National Industrial Base for Stem Cell Engineering Products, Government of the People's Republic of China - Department of Gastroenterology and Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases
Downloads 53 (686,824)
Citation 2

Abstract:

Loading...